Copyright Reports & Markets. All rights reserved.

Global Active Pharmaceutical Ingredients Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Active Pharmaceutical Ingredients

      • 1.1 Definition of Active Pharmaceutical Ingredients
      • 1.2 Active Pharmaceutical Ingredients Segment by Type
        • 1.2.1 Global Active Pharmaceutical Ingredients Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Synthetic
        • 1.2.3 Biotech
      • 1.3 Active Pharmaceutical Ingredients Segment by Applications
        • 1.3.1 Global Active Pharmaceutical Ingredients Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Diagnostic Laboratories
        • 1.3.3 Research & Academic Laboratories
        • 1.3.4 Pharmaceutical & Biotechnology Companies
      • 1.4 Global Active Pharmaceutical Ingredients Overall Market
        • 1.4.1 Global Active Pharmaceutical Ingredients Revenue (2014-2025)
        • 1.4.2 Global Active Pharmaceutical Ingredients Production (2014-2025)
        • 1.4.3 North America Active Pharmaceutical Ingredients Status and Prospect (2014-2025)
        • 1.4.4 Europe Active Pharmaceutical Ingredients Status and Prospect (2014-2025)
        • 1.4.5 China Active Pharmaceutical Ingredients Status and Prospect (2014-2025)
        • 1.4.6 Japan Active Pharmaceutical Ingredients Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Active Pharmaceutical Ingredients Status and Prospect (2014-2025)
        • 1.4.8 India Active Pharmaceutical Ingredients Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredients
      • 2.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients
      • 2.4 Industry Chain Structure of Active Pharmaceutical Ingredients

      3 Development and Manufacturing Plants Analysis of Active Pharmaceutical Ingredients

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Active Pharmaceutical Ingredients Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Active Pharmaceutical Ingredients
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Active Pharmaceutical Ingredients Production and Capacity Analysis
      • 4.2 Active Pharmaceutical Ingredients Revenue Analysis
      • 4.3 Active Pharmaceutical Ingredients Price Analysis
      • 4.4 Market Concentration Degree

      5 Active Pharmaceutical Ingredients Regional Market Analysis

      • 5.1 Active Pharmaceutical Ingredients Production by Regions
        • 5.1.1 Global Active Pharmaceutical Ingredients Production by Regions
        • 5.1.2 Global Active Pharmaceutical Ingredients Revenue by Regions
      • 5.2 Active Pharmaceutical Ingredients Consumption by Regions
      • 5.3 North America Active Pharmaceutical Ingredients Market Analysis
        • 5.3.1 North America Active Pharmaceutical Ingredients Production
        • 5.3.2 North America Active Pharmaceutical Ingredients Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Active Pharmaceutical Ingredients Import and Export
      • 5.4 Europe Active Pharmaceutical Ingredients Market Analysis
        • 5.4.1 Europe Active Pharmaceutical Ingredients Production
        • 5.4.2 Europe Active Pharmaceutical Ingredients Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Active Pharmaceutical Ingredients Import and Export
      • 5.5 China Active Pharmaceutical Ingredients Market Analysis
        • 5.5.1 China Active Pharmaceutical Ingredients Production
        • 5.5.2 China Active Pharmaceutical Ingredients Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Active Pharmaceutical Ingredients Import and Export
      • 5.6 Japan Active Pharmaceutical Ingredients Market Analysis
        • 5.6.1 Japan Active Pharmaceutical Ingredients Production
        • 5.6.2 Japan Active Pharmaceutical Ingredients Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Active Pharmaceutical Ingredients Import and Export
      • 5.7 Southeast Asia Active Pharmaceutical Ingredients Market Analysis
        • 5.7.1 Southeast Asia Active Pharmaceutical Ingredients Production
        • 5.7.2 Southeast Asia Active Pharmaceutical Ingredients Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Active Pharmaceutical Ingredients Import and Export
      • 5.8 India Active Pharmaceutical Ingredients Market Analysis
        • 5.8.1 India Active Pharmaceutical Ingredients Production
        • 5.8.2 India Active Pharmaceutical Ingredients Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Active Pharmaceutical Ingredients Import and Export

      6 Active Pharmaceutical Ingredients Segment Market Analysis (by Type)

      • 6.1 Global Active Pharmaceutical Ingredients Production by Type
      • 6.2 Global Active Pharmaceutical Ingredients Revenue by Type
      • 6.3 Active Pharmaceutical Ingredients Price by Type

      7 Active Pharmaceutical Ingredients Segment Market Analysis (by Application)

      • 7.1 Global Active Pharmaceutical Ingredients Consumption by Application
      • 7.2 Global Active Pharmaceutical Ingredients Consumption Market Share by Application (2014-2019)

      8 Active Pharmaceutical Ingredients Major Manufacturers Analysis

      • 8.1 Merck
        • 8.1.1 Merck Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.1.2 Merck Product Introduction, Application and Specification
        • 8.1.3 Merck Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novartis
        • 8.2.1 Novartis Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.2.2 Novartis Product Introduction, Application and Specification
        • 8.2.3 Novartis Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Pfizer
        • 8.3.1 Pfizer Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.3.2 Pfizer Product Introduction, Application and Specification
        • 8.3.3 Pfizer Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Roche
        • 8.4.1 Roche Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.4.2 Roche Product Introduction, Application and Specification
        • 8.4.3 Roche Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Sun Pharmaceutical Industries
        • 8.5.1 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.5.2 Sun Pharmaceutical Industries Product Introduction, Application and Specification
        • 8.5.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Teva Pharmaceutical Industries
        • 8.6.1 Teva Pharmaceutical Industries Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.6.2 Teva Pharmaceutical Industries Product Introduction, Application and Specification
        • 8.6.3 Teva Pharmaceutical Industries Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Abbott Laboratories
        • 8.7.1 Abbott Laboratories Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.7.2 Abbott Laboratories Product Introduction, Application and Specification
        • 8.7.3 Abbott Laboratories Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Emcure Pharmaceuticals
        • 8.8.1 Emcure Pharmaceuticals Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.8.2 Emcure Pharmaceuticals Product Introduction, Application and Specification
        • 8.8.3 Emcure Pharmaceuticals Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Ipca Laboratories
        • 8.9.1 Ipca Laboratories Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.9.2 Ipca Laboratories Product Introduction, Application and Specification
        • 8.9.3 Ipca Laboratories Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Johnson Matthey
        • 8.10.1 Johnson Matthey Active Pharmaceutical Ingredients Production Sites and Area Served
        • 8.10.2 Johnson Matthey Product Introduction, Application and Specification
        • 8.10.3 Johnson Matthey Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Guilin Pharmaceutical
      • 8.12 Johnson & Johnson
      • 8.13 Lonza Group

      9 Development Trend of Analysis of Active Pharmaceutical Ingredients Market

      • 9.1 Global Active Pharmaceutical Ingredients Market Trend Analysis
        • 9.1.1 Global Active Pharmaceutical Ingredients Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Active Pharmaceutical Ingredients Regional Market Trend
        • 9.2.1 North America Active Pharmaceutical Ingredients Forecast 2019-2025
        • 9.2.2 Europe Active Pharmaceutical Ingredients Forecast 2019-2025
        • 9.2.3 China Active Pharmaceutical Ingredients Forecast 2019-2025
        • 9.2.4 Japan Active Pharmaceutical Ingredients Forecast 2019-2025
        • 9.2.5 Southeast Asia Active Pharmaceutical Ingredients Forecast 2019-2025
        • 9.2.6 India Active Pharmaceutical Ingredients Forecast 2019-2025
      • 9.3 Active Pharmaceutical Ingredients Market Trend (Product Type)
      • 9.4 Active Pharmaceutical Ingredients Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Active Pharmaceutical Ingredients Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.
        Production of APIs has traditionally been done by the pharmaceutical companies themselves in their home countries. But in recent years many corporations have opted to send manufacturing overseas to cut costs.
        This has caused significant changes to how these drugs are regulated, with more rigorous guidelines and inspections put into place.

        The global Active Pharmaceutical Ingredients market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Active Pharmaceutical Ingredients volume and value at global level, regional level and company level. From a global perspective, this report represents overall Active Pharmaceutical Ingredients market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Active Pharmaceutical Ingredients in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Active Pharmaceutical Ingredients manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Merck
        Novartis
        Pfizer
        Roche
        Sun Pharmaceutical Industries
        Teva Pharmaceutical Industries
        Abbott Laboratories
        Emcure Pharmaceuticals
        Ipca Laboratories
        Johnson Matthey
        Guilin Pharmaceutical
        Johnson & Johnson
        Lonza Group

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Synthetic
        Biotech

        Segment by Application
        Diagnostic Laboratories
        Research & Academic Laboratories
        Pharmaceutical & Biotechnology Companies

        Buy now